- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05777408
Additional Effect of Cranial Base Release on Cervical Range and Proprioception in Patients With Mechanical Neck Pain
August 11, 2025 updated by: Foundation University Islamabad
Mechanical Neck pain is the second most commonly occurring musculoskeletal disorder worldwide, ranking 4th in overall disability.
It is referred to as Nonspecific generalized neck pain with mechanical characteristics with a primary location between the supranuchal line and the first thoracic spinous process, includingpatients suffering from mechanical neck pain are reported to have several impairments, including pain, reduced cervical ROM, neck disability, and proprioceptive dysfunction.
The treatment indicated involves the use of electrotherapy and thermal modalities.
In addition, the use of different manual therapy techniques is advocated; however, the most effective management is still debatable.
Evidence suggests that Natural Apophyseal glides have a significant positive effect on mechanical neck pain patients.
So the study will identify the additional effect of cranial base release with natural apophyseal glides in alleviating pain and its effects on proprioception.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Punjab
-
Rawalpindi, Punjab, Pakistan, 46000
- Foundation University College of Physical Therapy
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients diagnosed with mechanical neck pain having reproducible non-specific neck pain with a primary location between the supranuchal line and the first thoracic spinous process
- Male and Female
- Age 18-40 years
- Pain severity on NPRS >3
- Neck Disability score of 20% or above
- Problem not older than 2 months
Exclusion Criteria:
- Patients with history of
- Recent significant trauma (including whiplash)
- Radiculopathy
- Cervical fracture
- Neck surgery
- Dizziness, vertigo
- Myelopathy, Malignancy
- Metabolic disease
- Diagnosed Osteoporosis, Rheumatoid arthritis
- Long-term corticosteroid and/or painkiller drug use
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control Group
Participants of this group will receive the conventional physical therapy protocol mentioned above. In addition to this, they will receive Natural apophyseal glides 3 sets of 10 repetitions.
|
-Will be applied in sitting position Therapist right hand would cradle the head such that the little finger would rest on the spinous process of the vertebra that is to be mobilized.
The other hands thumb would be used to apply over pressure.
Direction of force will be parallel to highly irritable-grossly restricted cervical facet joints.
Intervention would involve 3 sets of 20 repetitions in 15minutes, 3 days a week for 2 weeks comprising of total 6 session.
|
|
Experimental: Experimental Group
|
-Will be applied in sitting position Therapist right hand would cradle the head such that the little finger would rest on the spinous process of the vertebra that is to be mobilized.
The other hands thumb would be used to apply over pressure.
Direction of force will be parallel to highly irritable-grossly restricted cervical facet joints.
Intervention would involve 3 sets of 20 repetitions in 15minutes, 3 days a week for 2 weeks comprising of total 6 session.
Will be performed in lying position.
therapist fingers will contact the sub occipital muscles and upward pressure would be given until the tissues and muscles relax.
it will be given once daily for 3 days a week and will continue for 2 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Pain
Time Frame: 2 weeks
|
Pain will be measured on Numeric Pain Rating Scale.
|
2 weeks
|
|
Change in ROM
Time Frame: 2 weeks
|
Cervical rotation will be measured through CROM device
|
2 weeks
|
|
Change in Cervical Proprioception
Time Frame: 2 weeks
|
Will be measured from Laser Pointer Method
|
2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2023
Primary Completion (Actual)
June 1, 2023
Study Completion (Actual)
July 1, 2023
Study Registration Dates
First Submitted
March 9, 2023
First Submitted That Met QC Criteria
March 20, 2023
First Posted (Actual)
March 21, 2023
Study Record Updates
Last Update Posted (Actual)
August 14, 2025
Last Update Submitted That Met QC Criteria
August 11, 2025
Last Verified
March 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FUI/CTR/2023/3
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.